Life ScienceCompany
Shenzhen Hepalink Pharmaceutical Group has acquired 3 companies. A total of 3 acquisitions came from private equity firms.
Shenzhen Hepalink Pharmaceutical Group’s largest acquisition to date was in 2014, when it acquired Scientific Protein Laboratories for $338M. Shenzhen Hepalink Pharmaceutical Group has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Shenzhen Hepalink Pharmaceutical Group’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 3
- M&A Advisors 1